AbbVie Seeks New Trial After $140M AndroGel Verdict
AbbVie Inc. on Tuesday asked an Illinois federal judge for a new trial in the second bellwether case over claims the drugmaker failed to warn consumers about risks accompanying its testosterone...To view the full article, register now.
Already a subscriber? Click here to view full article